Fall Clinical 2025 News: Emrosi Bests Oracea in Phase 3 Rosacea Trials
Emrosi (minocycline HCl, Journey Medical Corporation) bested oracea (doxycycline, Galderma) and placebo in a pooled analysis of two Phase 3 rosacea trials.
Category: Rosacea
Emrosi (minocycline HCl, Journey Medical Corporation) bested oracea (doxycycline, Galderma) and placebo in a pooled analysis of two Phase 3 rosacea trials.